Y. Ding

First name
Last name
Margulis, A. V., Abou-Ali, A., Strazzeri, M. M., Ding, Y., Kuyateh, F., . Y. Frimpong, E., et al. (2013). Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3462
Hammad, T. A., Margulis, A. V., Ding, Y., Strazzeri, M. M., & Epperly, H. (2013). Determining the predictive value of Read codes to identify congenital cardiac malformations in the UK Clinical Practice Research Datalink. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3511
Alexander, M., Ding, Y., Foskett, N., Petri, H., Wandel, C., & Khwaja, O. (2016). Population prevalence of Down\textquoterights syndrome in the United Kingdom. J Intellect Disabil Res. http://doi.org/10.1111/jir.12277
Alexander, M., Petri, H., Ding, Y., Wandel, C., Khwaja, O., & Foskett, N. (2016). Morbidity and medication in a large population of individuals with Down syndrome compared to the general population. Dev Med Child Neurol. http://doi.org/10.1111/dmcn.12868
Bakhai, A., Petri, H., Vahidnia, F., Wolf, C., Ding, Y., Foskett, N., & Sculpher, M. (2020). Real-world data on the incidence, mortality, and cost of ischaemic stroke and major bleeding events among non-valvular atrial fibrillation patients in England. J Eval Clin Pract. http://doi.org/10.1111/jep.13400